Overcoming Tumor Drug Resistance
Lyon, France
Joined March 2012
- Tweets114
- Following112
- Followers194
- Likes11
ABD's work has been selected by the scientific committee for an ORAL presentation at #EACR2023 congress in Turin, Italy. linkedin.com/posts/ismail-ce…
I am very happy to announce our participation in the #EHA2023 from June 8-11 in Frankfurt where we will be represented by Mileidys Perez (CSO). Through a poster entitled “ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA". EHA Library. Shaikh M. 06/08/2023; 386279; P450
Advanced BioDesign retweeted
📣 Happening today!
Half-time retreat Day#4 with Mileidys Perez - @ABioDesign Aude Veinante Gardey - @LAVOIX_IP Joris van Arensbergen @JArensbergen - Annogen B.V. Koen Verhoef @NKI_nl and Carlo Chiavaroli - @VCLSsocial
@MSCActions
Today is Triple-Negative Breast Cancer (#TNBC) Day. @ABioDesign, we are committed to fight against this aggressive cancer with its promising approach using #ALDHinhibitors.
#cancer #tumorresistance
@ABioDesign receives the authorization from the French autohorities for its "First-In-Human" clinical trial "#ODYSSEY"
bit.ly/33TqDl6
Initiate in 2020, our collaboration with the TIME team and Dr Bassam Janji is evolving into a new dimension with the “TRICK-ALDH” project. This collaboration will accelerate the launch of our innovative approach for the benefit of patients.
lih.lu/blog/our-news-1/post/…
We are #hiring a #postdoctoral position #postdocjobs. 💼
Do you know someone who might be interested?👀
If you fulfill the eligibility criteria and provide the above requirements, send your application.
linkedin.com/jobs/view/26695…
Advanced BioDesign retweeted
Interested in #enhancers and their role in human disease? Join the @EMBO workshop co-organized by @IglesiadRada @S_Spicuglia @susmandrup
Registration 👉 bit.ly/3bBNIc9
Registr. deadline 👉27 August 2021
Abstract submission deadline 👉27 August 2021
#EMBOenhanceropathies
Advanced BioDesign retweeted
Here my first post for "All Eyes On Enhancers" #AEOE blog by @enhpathy_H2020 about my PhD project.
@ABioDesign @MSCActions #enhanceropathies
enhpathy.eu/sfa-post/uncover…
Today is #TNBCDay. At @ABioDesign we're working on the development of a new approach for resistant cancer like #tnbc with our program THERALDIN®TNBC. #oncology #tumorresistance
bit.ly/3e2EgkD
Advanced BioDesign retweeted
#JournéeInternationaleDuCancerDeLenfant « Se mobiliser pour faire reculer les cancers de l’enfant, de l’adolescent et du jeune adulte » est l’une des actions clés de la nouvelle #stratégieCancers, figurant dans la feuille de route 2021-2025. En savoir plus bit.ly/2MPz74t
Despite breakthroughs treatments in #BreastCancer, the disease continues to affect millions of people. #TNBC (15% of #BreastCancer) have aggressive behaviour and lack of therapies. @ABioDesign is committed to create alternative for #TNBC. #pinktober
bit.ly/33ZXQsv
@ABioDesign and Dr @bassam_janji and his team TIME (Tumor Immunotherapy and Microenvironment) from @LIH_Luxembourg will collaborate on tumour resistance.
bit.ly/3ieb0at
#oncology #precisionmedecine #tumorresistance
🎙 @ceylan_abd sur @Biotech_finance en partenariat avec @FranceBiotech pour évoquer le développement d'@ABioDesign
youtu.be/ezG_1VRNa0c
Platinum-based chemotherapy resistance is a major hurdle limiting treatment success in NSCLC. Recently, @ABioDesign publish in @oncogenejournal a real alternative to overcome this problem #targetedtherapy #precisionmedicine #lungcancer #oncology
nature.com/articles/s41388-0…
Advanced BioDesign retweeted
Today's the last day to apply for the @enhpathy_H2020 PhD program from ITN @MSCActions. Ambitious international students who want to work on function and mechanisms of transcriptional enhancers in human diseases, apply here: enhpathy.eu
PhD Projects call are still open. Submit your application.
Apply here bit.ly/2Qghp8C
@MSCActions @enhpathy_H2020
Advanced BioDesign retweeted
OPEN CALL 15 PhD PROJECTS - Submit your application today! Apply here 👉 bit.ly/2Qghp8C
@MSCActions @Mariecurie_alum @YERUN_EU @Eurodoc
Advanced BioDesign retweeted
Advanced BioDesign rejoint le consortium ENHPATHY qui va recevoir un financement de 4 millions d’euros sur 4 ans mypharma-editions.com/advanc…
@ABioDesign through @enhpathy_H2020 is looking for PhD. Call open in March 2020.
Apply here -> enhpathy.eu/recruitment/
#drugdiscovery #translationalresearch #epigenomics #targetedtherapy
